SGK1-IN-8 (compound 55) is a SGK1 and GSK3β inhibitor, with an IC 50 of 0.11 μM against human SGK1 and an IC 50 of 3.39 μM against human GSK3β . SGK1-IN-8 inhibits the catalytic activities of SGK1 and GSK3β , and reduces the phosphorylation level of TAU protein at the Ser214 site. SGK1-IN-8 is available for the research of Alzheimer's disease.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > SGK
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。